Role of infections in atherosclerosis

V V Valtonen1

  • 1Division of Infectious Diseases, Department of Medicine, Helsinki, Finland.

American Heart Journal
|October 28, 1999
PubMed

Insights

Infections, including bacteremic and chronic types like Chlamydia pneumoniae, are increasingly recognized as significant risk factors for atherosclerotic diseases such as heart attack and stroke.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Pathogenesis of Atherosclerosis

Background:

  • Epidemiologic, experimental, and clinical studies increasingly link infections to atherosclerotic diseases.
  • Bacteremic infections, with or without endocarditis, elevate the risk of stroke and myocardial infarction.
  • Chronic infections, including Chlamydia pneumoniae and dental infections, are implicated in atherosclerotic disease development.

Purpose of the Study:

  • To review the evidence linking infections to atherosclerotic diseases.
  • To explore the potential role of infections in the etiopathogenesis of atherosclerosis.
  • To discuss the complex and multifactorial mechanisms underlying the infection-atherosclerosis association.

Main Methods:

  • Review of existing epidemiologic, experimental, and clinical evidence.
  • Analysis of the association between various types of infections and atherosclerotic outcomes.
  • Discussion of proposed pathogenetic mechanisms.

Main Results:

  • Infections are established risk factors for acute myocardial infarction and cerebral infarction.
  • Chronic bacterial infections may contribute to the atherosclerotic process itself.
  • Mechanisms linking infection and atherosclerosis are complex, multifactorial, and patient-specific.

Conclusions:

  • Infection is a significant risk factor for atherosclerotic diseases, acting both independently and synergistically with traditional risk factors.
  • The role of infection in atherosclerosis is complex and warrants further investigation.
  • Understanding these mechanisms is crucial for developing novel prevention and treatment strategies for cardiovascular events.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...